SCI Pharmtech, Inc. (TPE:4119)

SCI Pharmtech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	250.91	582.38	942.06	166.83	332.23	633.03
Trading Asset Securities	107.7	110.37	89	97.55	360.4	-
Cash & Short-Term Investments	358.6	692.76	1,031	264.37	692.63	633.03
Cash Growth	-60.66%	-32.81%	290.00%	-61.83%	9.42%	-37.91%
Accounts Receivable	212.93	289.51	307.37	173.57	82.98	337.75
Other Receivables	0.02	-	0.15	31.1	265.59	519.65
Receivables	212.94	289.51	307.52	204.67	348.56	857.4
Inventory	611.42	620.9	529.53	513.43	294.18	380.88
Other Current Assets	70.96	57.22	85.13	59.93	61.93	47.5
Total Current Assets	1,254	1,660	1,953	1,042	1,397	1,919
Property, Plant & Equipment	5,055	4,803	3,912	3,194	2,100	1,503
Long-Term Investments	254.84	237.52	241.62	208.04	124.97	753.65
Other Intangible Assets	33.73	37.77	46.15	54.58	60.29	41.32
Long-Term Deferred Tax Assets	143.82	143.82	153.28	167.25	241.55	263.55
Other Long-Term Assets	273.38	318.06	384.69	294.11	265.64	89.89
Total Assets	7,014	7,201	6,691	4,961	4,190	4,570
Accounts Payable	72.09	58.44	44.25	48.64	33.78	80.88
Accrued Expenses	-	116.05	110.72	128.35	121.46	204.76
Short-Term Debt	0.1	0.1	175	112	-	-
Current Portion of Long-Term Debt	455.17	403.44	20	-	-	-
Current Portion of Leases	4.58	2.47	1.95	0.83	1.58	1.34
Current Income Taxes Payable	29.37	85.25	11.54	3.86	-	127.49
Current Unearned Revenue	35.08	94.92	38.37	31.77	41.76	97.3
Other Current Liabilities	420.15	253.72	168.07	444.86	549.35	610.45
Total Current Liabilities	1,017	1,014	569.89	770.32	747.94	1,122
Long-Term Debt	402.68	578.01	842.67	432.36	-	-
Long-Term Leases	44.66	6.37	2.86	0.2	0.57	1.25
Long-Term Unearned Revenue	-	-	-	4.11	-	-
Long-Term Deferred Tax Liabilities	104.45	104.45	146	103.81	103.81	103.81
Other Long-Term Liabilities	63.41	8.68	7.84	1	-	-
Total Liabilities	1,632	1,724	1,591	1,331	869.26	1,248
Common Stock	1,195	1,195	1,195	953.82	953.82	794.85
Additional Paid-In Capital	2,235	2,235	2,234	1,357	1,348	1,348
Retained Earnings	1,912	2,037	1,646	1,373	1,067	1,208
Comprehensive Income & Other	40.4	10.07	25.46	-54.73	-48.93	-29.38
Shareholders' Equity	5,383	5,477	5,100	3,629	3,321	3,322
Total Liabilities & Equity	7,014	7,201	6,691	4,961	4,190	4,570
Total Debt	907.19	990.39	1,042	545.38	2.16	2.59
Net Cash (Debt)	-548.59	-297.63	-11.42	-281.01	690.48	630.44
Net Cash Growth	-	-	-	-	9.52%	-37.98%
Net Cash Per Share	-4.60	-2.48	-0.10	-2.61	6.42	5.84
Filing Date Shares Outstanding	119.92	119.51	119.51	107.3	107.3	107.3
Total Common Shares Outstanding	119.92	119.51	119.51	107.3	107.3	107.3
Working Capital	237.39	646.01	1,383	272.08	649.37	796.6
Book Value Per Share	44.89	45.83	42.67	33.82	30.95	30.96
Tangible Book Value	5,349	5,439	5,054	3,575	3,260	3,281
Tangible Book Value Per Share	44.60	45.51	42.29	33.31	30.38	30.58
Land	-	687.88	687.88	687.88	825.68	825.68
Buildings	-	722.9	707	700.23	684.47	553.52
Machinery	-	2,467	1,786	1,185	577.08	576.8
Construction In Progress	-	1,965	1,565	1,323	633.3	222.71

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.